Geoff Oxnard, Thoracic Oncologist at Boston Medical Center, shared a post on X:
“Fantastic energy this week presenting preliminary findings from our SOLARA trial of BH-30643 in Boston.
Please check out the poster which is now on the BHT pipeline website! Study enrolling full steam ahead with a focus on on-target resistance and TKI-naive EGFR-mutant NSCLC.”
You Can Also Read:
